Longitudinal functional magnetic resonance imaging of cognition in preclinical Huntington's disease

Experimental Neurology

Volumn 231, Issue 2, 2011, Pages 214-222

  Wolf, Robert Christian ^a,b   Sambataro, Fabio ^c   Vasic, Nenad ^b   Wolf, Nadine Donata ^b,d   Thomann, Philipp Arthur ^a   Landwehrmeyer, G Bernhard ^b   Orth, Michael ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^d CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Biomarker; Functional magnetic resonance imaging; Huntington's disease; Preclinical; Prefrontal cortex; Working memory

Indexed keywords

ADULT; ARTICLE; ATTENTION; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; HUNTINGTON CHOREA; IMAGE ANALYSIS; LONGITUDINAL STUDY; MALE; NEUROANATOMY; NEUROPSYCHOLOGICAL TEST; ONSET AGE; OPTICAL RESOLUTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; VOXEL BASED MORPHOMETRY; WORKING MEMORY;

ADULT; BRAIN; BRAIN MAPPING; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; HUNTINGTON DISEASE; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 80052537333     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.06.011     Document Type: Article

References (48)

1. Ashburner J., Friston K.J. Voxel-based morphometry - the methods. Neuroimage 2000, 11:805-821.
2. Aylward E.H. Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease. Brain Res. Bull. 2007, 72:152-158.
3. Baddeley A. Working memory: looking back and looking forward. Nat. Rev. Neurosci. 2003, 4:829-839.
4. Biglan K.M., Ross C.A., Langbehn D.R., Aylward E.H., Stout J.C., Queller S., Carlozzi N.E., Duff K., Beglinger L.J., Paulsen J.S. Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study. Mov. Disord. 2009, 24:1763-1772.
5. Bohanna I., Georgiou-Karistianis N., Hannan A.J., Egan G.F. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease. Brain Res. Rev. 2008, 58:209-225.
6. Brandt J., Shpritz B., Codori A.M., Margolis R., Rosenblatt A. Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals. J. Int. Neuropsychol. Soc. 2002, 8:918-924.
7. Brandt J., Inscore A.B., Ward J., Shpritz B., Rosenblatt A., Margolis R.L., Ross C.A. Neuropsychological deficits in Huntington's disease gene carriers and correlates of early "conversion". J. Neuropsychiatry Clin. Neurosci. 2008, 20:466-472.
8. Duff K., Paulsen J., Mills J., Beglinger L.J., Moser D.J., Smith M.M., Langbehn D., Stout J., Queller S., Harrington D.L. Mild cognitive impairment in prediagnosed Huntington disease. Neurology 2010, 75:500-507.
9. Feigin A., Tang C., Ma Y., Mattis P., Zgaljardic D., Guttman M., Paulsen J.S., Dhawan V., Eidelberg D. Thalamic metabolism and symptom onset in preclinical Huntington's disease. Brain 2007, 130:2858-2867.
10. Friston K.J., Holmes A., Worsley K.J., Poline J.B., Frith C.D., Frackowiak R.S.J. Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapp. 1995, 2:189-210.
11. Friston K.J., Holmes A.P., Poline J.B., Grasby P.J., Williams S.C., Frackowiak R.S., Turner R. Analysis of fMRI time-series revisited. Neuroimage 1995, 2:45-53.
12. Gomez-Anson B., Alegret M., Munoz E., Monte G.C., Alayrach E., Sanchez A., Boada M., Tolosa E. Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number. Parkinsonism Relat. Disord. 2009, 15:213-219.
13. Henley S.M., Wild E.J., Hobbs N.Z., Scahill R.I., Ridgway G.R., Macmanus D.G., Barker R.A., Fox N.C., Tabrizi S.J. Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease. J. Neurol. 2009, 256:203-212.
14. Hobbs N.Z., Henley S.M., Ridgway G.R., Wild E.J., Barker R.A., Scahill R.I., Barnes J., Fox N.C., Tabrizi S.J. The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study. J. Neurol. Neurosurg. Psychiatry 2010, 81:756-763.
15. Huntington-Study-Group Unified Huntington's Disease Rating Scale: reliability and consistency. Mov. Disord. 1996, 11:136-142.
16. Kipps C.M., Duggins A.J., Mahant N., Gomes L., Ashburner J., McCusker E.A. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. J. Neurol. Neurosurg. Psychiatry 2005, 76:650-655.
17. Kirkwood S.C., Siemers E., Stout J.C., Hodes M.E., Conneally P.M., Christian J.C., Foroud T. Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Arch. Neurol. 1999, 56:563-568.
18. Kloppel S., Draganski B., Siebner H.R., Tabrizi S.J., Weiller C., Frackowiak R.S. Functional compensation of motor function in pre-symptomatic Huntington's disease. Brain 2009, 132:1624-1632.
19. Kloppel S., Henley S.M., Hobbs N.Z., Wolf R.C., Kassubek J., Tabrizi S.J., Frackowiak R.S. Magnetic resonance imaging of Huntington's disease: preparing for clinical trials. Neuroscience 2009, 164:205-219.
20. Langbehn D.R., Brinkman R.R., Falush D., Paulsen J.S., Hayden M.R., Group I.H.s.D.C. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 2004, 65:267-277.
21. Lawrence A.D., Hodges J.R., Rosser A.E., Kershaw A., ffrench-Constant C., Rubinsztein D.C., Robbins T.W., Sahakian B.J. Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 1998, 121(Pt 7):1329-1341.
22. Lemiere J., Decruyenaere M., Evers-Kiebooms G., Vandenbussche E., Dom R. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation - a longitudinal follow-up study. J. Neurol. 2004, 251:935-942.
23. Nehl C., Ready R.E., Hamilton J., Paulsen J.S. Effects of depression on working memory in presymptomatic Huntington's disease. J. Neuropsychiatry Clin. Neurosci. 2001, 13:342-346.
24. Nelson H.E. A modified card sorting test sensitive to frontal lobe defects. Cortex 1976, 12:313-324.
25. Nopoulos P.C., Aylward E.H., Ross C.A., Mills J.A., Langbehn D.R., Johnson H.J., Magnotta V.A., Pierson R.K., Beglinger L.J., Nance M.A., Barker R.A., Paulsen J.S. Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment. Brain 2011, 134:137-142.
26. Paulsen J.S., Zhao H., Stout J.C., et al. Clinical markers of early disease in persons near onset of Huntington's disease. Neurology 2001, 658-662.
27. Paulsen J.S., Magnotta V.A., Mikos A.E., Paulson H.L., Penziner E., Andreasen N.C., Nopoulos P.C. Brain structure in preclinical Huntington's disease. Biol. Psychiatry 2006, 59:57-63.
28. Paulsen J.S., Langbehn D.R., Stout J.C., Aylward E., Ross C.A., Nance M., Guttman M., Johnson S., MacDonald M., Beglinger L.J., Duff K., Kayson E., Biglan K., Shoulson I., Oakes D., Hayden M. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J. Neurol. Neurosurg. Psychiatry 2008, 79:874-880.
29. Paulsen J.S., Nopoulos P.C., Aylward E., Ross C.A., Johnson H., Magnotta V.A., Juhl A., Pierson R.K., Mills J., Langbehn D., Nance M. Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res. Bull. 2010, 82:201-207.
30. Perlstein W.M., Carter C.S., Barch D.M., Baird J.W. The Stroop task and attention deficits in schizophrenia: a critical evaluation of card and single-trial Stroop methodologies. Neuropsychology 1998, 12:414-425.
31. Rosas H.D., Hevelone N.D., Zaleta A.K., Greve D.N., Salat D.H., Fischl B. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 2005, 65:745-747.
32. Rupp J., Blekher T., Jackson J., Beristain X., Marshall J., Hui S., Wojcieszek J., Foroud T. Progression in prediagnostic Huntington disease. J. Neurol. Neurosurg. Psychiatry 2009, 81:379-384.
33. Saft C., Schuttke A., Beste C., Andrich J., Heindel W., Pfleiderer B. fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease. Neuropsychologia 2008, 46:1279-1289.
34. Saft C., Kosinski C.M., Landwehrmeyer B. Progress in premanifest and manifest diagnostics in huntington's disease. Aktuelle Neurol. 2009, 36:506-523.
35. Snowden J.S., Craufurd D., Thompson J., et al. Psychomotor, executive, and memory function in preclinical Huntington's disease. J. Clin. Exp. Neuropsychol. 2002, 24:133-145.
36. Solomon A.C., Stout J.C., Weaver M., Queller S., Tomusk A., Whitlock K.B., Hui S.L., Marshall J., Jackson J.G., Siemers E.R., Beristain X., Wojcieszek J., Foroud T. Ten-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease. Mov. Disord. 2008, 23:1830-1836.
37. Spitzer M., Franke B., Walter H., Buechler J., Wunderlich A.P., Schwab M., Kovar K., Hermle L., Gron G. Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans. Neuropharmacology 2001, 41:263-271.
38. Sternberg S. High-speed scanning in human memory. Science 1966, 153:652-654.
39. Stoffers D., Sheldon S., Kuperman J.M., Goldstein J., Corey-Bloom J., Aron A.R. Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study. Neurology 2010, 74:1208-1216.
40. Stroop J.R. Studies of interference in serial verbal reactions. J. Exp. Psychol. Learn. Mem. Cogn. 1935, 18:643-662.
41. Tabrizi S.J., Langbehn D.R., Leavitt B.R., Roos R.A., Durr A., Craufurd D., Kennard C., Hicks S.L., Fox N.C., Scahill R.I., Borowsky B., Tobin A.J., Rosas H.D., Johnson H., Reilmann R., Landwehrmeyer B., Stout J.C. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 2009, 8:791-801.
42. Talairach J., Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain 1988, Thieme Medical Publishers, New York, NY.
43. van Oostrom J.C., Dekker M., Willemsen A.T., de Jong B.M., Roos R.A., Leenders K.L. Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington's disease. Eur. J. Neurol. 2009, 16:226-231.
44. Vonsattel J.P., Myers R.H., Stevens T.J. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 1985, 44:559-577.
45. Wolf R.C., Walter H. Evaluation of a novel event-related parametric fMRI paradigm investigating prefrontal function. Psychiatry Res. Neuroimaging 2005, 140:73-83.
46. Wolf R.C., Vasic N., Schonfeldt-Lecuona C., Landwehrmeyer G.B., Ecker D. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain 2007, 130:2845-2857.
47. Zimbelman J.L., Paulsen J.S., Mikos A.E., Reynolds N.C., Hoffman R.G., Rao S.M. fMRI detection of early neural dysfunction in preclinical Huntington's disease. J. Int. Neuropsychol. Soc. 2007, 13:758-769.
48. Zimmermann P., Fimm B. Testbatterie zur Aufmerksamkeitsprüfung (TAP) 1994, Psytest, Herzogenrath.